Clare Keddy

400 total citations
6 papers, 224 citations indexed

About

Clare Keddy is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Clare Keddy has authored 6 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Clare Keddy's work include Lung Cancer Treatments and Mutations (6 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer therapeutics and mechanisms (2 papers). Clare Keddy is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer therapeutics and mechanisms (2 papers). Clare Keddy collaborates with scholars based in United States. Clare Keddy's co-authors include Monika A. Davare, Alexander Drilon, Adam J. Schoenfeld, Chelsea Jenkins, Kristen L. Jones, Ujwal Shinde, Romel Somwar, Stefanie Kaech, Kevin D. Nusser and Kellie J. Nazemi and has published in prestigious journals such as Cancer Research, Nature Reviews Clinical Oncology and Molecular Cancer Therapeutics.

In The Last Decade

Clare Keddy

6 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clare Keddy United States 5 147 114 114 61 22 6 224
Chelsea Jenkins United States 4 118 0.8× 114 1.0× 105 0.9× 60 1.0× 16 0.7× 5 216
Dionysis Papadatos-Pastos United Kingdom 9 73 0.5× 136 1.2× 99 0.9× 56 0.9× 16 0.7× 20 278
Morana Vojnic United States 7 165 1.1× 129 1.1× 132 1.2× 45 0.7× 41 1.9× 24 276
Sarah Ftouni Australia 5 65 0.4× 113 1.0× 94 0.8× 100 1.6× 36 1.6× 11 231
Amaya Gascó Spain 7 164 1.1× 98 0.9× 159 1.4× 95 1.6× 25 1.1× 18 248
Troy M. Robinson United States 4 78 0.5× 159 1.4× 112 1.0× 47 0.8× 23 1.0× 6 255
S. Gadgeel United States 5 153 1.0× 133 1.2× 129 1.1× 67 1.1× 25 1.1× 16 262
Marta Román Spain 5 126 0.9× 168 1.5× 116 1.0× 68 1.1× 22 1.0× 7 306
Mónica Garzón Spain 5 150 1.0× 153 1.3× 105 0.9× 117 1.9× 51 2.3× 6 263
M. Campone France 8 86 0.6× 79 0.7× 128 1.1× 44 0.7× 16 0.7× 21 217

Countries citing papers authored by Clare Keddy

Since Specialization
Citations

This map shows the geographic impact of Clare Keddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare Keddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare Keddy more than expected).

Fields of papers citing papers by Clare Keddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare Keddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare Keddy. The network helps show where Clare Keddy may publish in the future.

Co-authorship network of co-authors of Clare Keddy

This figure shows the co-authorship network connecting the top 25 collaborators of Clare Keddy. A scholar is included among the top collaborators of Clare Keddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clare Keddy. Clare Keddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Thawani, Rajat, Matteo Repetto, Clare Keddy, et al.. (2024). TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers. npj Precision Oncology. 8(1). 175–175. 5 indexed citations
2.
Nusser, Kevin D., Kristen L. Jones, Clare Keddy, et al.. (2023). Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors. EMBO Molecular Medicine. 15(10). e17367–e17367. 4 indexed citations
3.
Tangpeerachaikul, Anupong, et al.. (2022). Abstract 3336: Preclinical activity of NVL-520 in ROS1-driven cancer models with diverse fusion partners and kinase-domain mutations. Cancer Research. 82(12_Supplement). 3336–3336. 1 indexed citations
4.
Keddy, Clare, Kristen L. Jones, Stefanie Kaech, et al.. (2021). Resistance Profile and Structural Modeling of Next-Generation ROS1 Tyrosine Kinase Inhibitors. Molecular Cancer Therapeutics. 21(2). 336–346. 30 indexed citations
5.
Keddy, Clare, Tanaya Neff, Joshua P. Nickerson, et al.. (2021). Mechanisms of targeted therapy resistance in a pediatric glioma driven by ETV6-NTRK3 fusion. Molecular Case Studies. 7(5). a006109–a006109. 9 indexed citations
6.
Drilon, Alexander, et al.. (2020). ROS1-dependent cancers — biology, diagnostics and therapeutics. Nature Reviews Clinical Oncology. 18(1). 35–55. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026